Siftr is a precision therapeutics company that is currently in development.
Siftr Bio has raised $1.3M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2024.
Siftr Bio's investors include Wilbe Capital, Endeavor8.
Siftr Bio is headquartered in London, United Kingdom.
Siftr is a precision therapeutics company that is currently in development.
Siftr Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Siftr Bio — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/siftr-bio. Accessed September 15, 2026.
VCBacked. (2024). Siftr Bio — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/siftr-bio
{{cite web |title=Siftr Bio — Funding & Investors |url=https://www.vcbacked.co/company/siftr-bio |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated